These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 15352538
1. New options in the pharmacological management of attention-deficit/hyperactivity disorder. Olfson M. Am J Manag Care; 2004 Jul; 10(4 Suppl):S117-24. PubMed ID: 15352538 [Abstract] [Full Text] [Related]
3. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM, Earls MF. Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [Abstract] [Full Text] [Related]
6. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments. Prince JB. Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):13-50. PubMed ID: 16321724 [Abstract] [Full Text] [Related]
7. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK. Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731 [Abstract] [Full Text] [Related]
8. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P. Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137 [Abstract] [Full Text] [Related]
10. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML, American Academy of Pediatrics Committee on Quality Improvement, American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder. Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203 [Abstract] [Full Text] [Related]
12. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder. Biederman J, Wigal SB, Spencer TJ, McGough JJ, Mays DA. Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649 [Abstract] [Full Text] [Related]
15. Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologists. Wigal SB, Chae S, Patel A, Steinberg-Epstein R. Semin Pediatr Neurol; 2010 Dec; 17(4):230-6. PubMed ID: 21183129 [Abstract] [Full Text] [Related]
18. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications. Varley CK, Vincent J, Varley P, Calderon R. Compr Psychiatry; 2001 Dec; 42(3):228-33. PubMed ID: 11349243 [Abstract] [Full Text] [Related]
19. A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder. Wigal SB, McGough JJ, McCracken JT, Biederman J, Spencer TJ, Posner KL, Wigal TL, Kollins SH, Clark TM, Mays DA, Zhang Y, Tulloch SJ. J Atten Disord; 2005 Aug; 9(1):275-89. PubMed ID: 16371674 [Abstract] [Full Text] [Related]